List of ASKA Pharmaceutical patents

Patents where

Current Assignee

Name

ASKA Pharmaceutical

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7799775 Pyrimidine derivatives	Patent 7799775 was granted and assigned to ASKA Pharmaceutical on September, 2010 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	7799775	September 21, 2010
‌ US Patent 7939536 Pyrimidinylisoxazole derivatives	Patent 7939536 was granted and assigned to ASKA Pharmaceutical on May, 2011 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	7939536	May 10, 2011
‌ US Patent 8207203 Pyridylisoxazole derivatives	Patent 8207203 was granted and assigned to ASKA Pharmaceutical on June, 2012 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	8207203	June 26, 2012
‌ US Patent 9040536 Substituted pyrrolo[1,2-a]quinoxalines as PDE9 inhibitors	Patent 9040536 was granted and assigned to ASKA Pharmaceutical on May, 2015 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	9040536	May 26, 2015
‌ US Patent 9365553 Heterocyclic compound and H1 receptor antagonist	Patent 9365553 was granted and assigned to ASKA Pharmaceutical on June, 2016 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	9365553	June 14, 2016
‌ US Patent 8299080 Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor	Patent 8299080 was granted and assigned to ASKA Pharmaceutical on October, 2012 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	8299080	October 30, 2012
‌ US Patent 11234928 Powder preparation for nasal administration	Patent 11234928 was granted and assigned to ASKA Pharmaceutical on February, 2022 by the United States Patent and Trademark Office.	ASKA Pharmaceutical	ASKA Pharmaceutical	United States Patent and Trademark Office	11234928	February 1, 2022
‌ US Patent 7449466 Cyclic aminophenyl sulfamate derivative	Patent 7449466 was granted and assigned to ASKA Pharmaceutical on November, 2008 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	7449466	November 11, 2008
‌ US Patent 8377944 Thienopyrimidine derivatives	Patent 8377944 was granted and assigned to ASKA Pharmaceutical on February, 2013 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	8377944	February 19, 2013
‌ US Patent 8193356 Heterocycle compound, and production process and application thereof	Patent 8193356 was granted and assigned to ASKA Pharmaceutical on June, 2012 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	8193356	June 5, 2012
‌ US Patent 8722094 Solid dispersion and pharmaceutical composition of the same, and production processes thereof	Patent 8722094 was granted and assigned to ASKA Pharmaceutical on May, 2014 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	8722094	May 13, 2014
‌ US Patent 9006253 Crystal of 2-(3,4-dichlorobenzyl)-5-methyl-4-oxo-3,4-dihydrothieno[2,3-D]pyrimidine-6-carboxylic acid	Patent 9006253 was granted and assigned to ASKA Pharmaceutical on April, 2015 by the United States Patent and Trademark Office.	ASKA Pharmaceutical	ASKA Pharmaceutical	United States Patent and Trademark Office	9006253	April 14, 2015
‌ US Patent 10508130 Crystalline polymorph of 15B-hydroxy-osaterone acetate	Patent 10508130 was granted and assigned to ASKA Pharmaceutical on December, 2019 by the United States Patent and Trademark Office.	ASKA Pharmaceutical	ASKA Pharmaceutical	United States Patent and Trademark Office	10508130	December 17, 2019
‌ US Patent 9643994 Crystalline polymorphic form of ulipristal acetate	Patent 9643994 was granted and assigned to ASKA Pharmaceutical on May, 2017 by the United States Patent and Trademark Office.	ASKA Pharmaceutical	ASKA Pharmaceutical	United States Patent and Trademark Office	9643994	May 9, 2017
‌ US Patent 9643993 Crystalline polymorphic form of ulipristal acetate	Patent 9643993 was granted and assigned to ASKA Pharmaceutical on May, 2017 by the United States Patent and Trademark Office.	ASKA Pharmaceutical	ASKA Pharmaceutical	United States Patent and Trademark Office	9643993	May 9, 2017
‌ US Patent 10815268 15-oxosteroid compound and process for producing the same		ASKA Pharmaceutical	ASKA Pharmaceutical	United States Patent and Trademark Office	10815268	October 27, 2020
‌ US Patent 8980872 Agent for preventing and/or treating functional gastrointestinal disorder	Patent 8980872 was granted and assigned to ASKA Pharmaceutical on March, 2015 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	8980872	March 17, 2015
‌ US Patent 9200008 Heterocyclic compound and p27	Patent 9200008 was granted and assigned to ASKA Pharmaceutical on December, 2015 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	9200008	December 1, 2015
‌ US Patent 10710967 Pyrimidine derivative		ASKA Pharmaceutical	ASKA Pharmaceutical	United States Patent and Trademark Office	10710967	July 14, 2020
‌ US Patent 8329649 Aqueous composition containing follicle-stimulating hormone and histidine	Patent 8329649 was granted and assigned to ASKA Pharmaceutical on December, 2012 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	8329649	December 11, 2012
‌ US Patent 7608716 Pyrazolonaphthyridine derivative	Patent 7608716 was granted and assigned to ASKA Pharmaceutical on October, 2009 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	7608716	October 27, 2009
‌ US Patent 8829000 Substituted imidazo[1,5-A]quinoxalines as phosphodiesterase 9 inhibitors			ASKA Pharmaceutical	United States Patent and Trademark Office	8829000	September 9, 2014
‌ US Patent 8748437 Crystal of 2-(3,4 dichlorobenzyl)-5-methyl-4-oxo-3,4-dihydrothien[2,3-D]pyrimidine-6-carboxylic acid	Patent 8748437 was granted and assigned to ASKA Pharmaceutical on June, 2014 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	8748437	June 10, 2014
‌ US Patent 8034801 Analgesic agent	Patent 8034801 was granted and assigned to ASKA Pharmaceutical on October, 2011 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	8034801	October 11, 2011
‌ US Patent 8101624 Quinazoline derivatives	Patent 8101624 was granted and assigned to ASKA Pharmaceutical on January, 2012 by the United States Patent and Trademark Office.		ASKA Pharmaceutical	United States Patent and Trademark Office	8101624	January 24, 2012

Results per page:

28 results

0 selected

28 results

0 selected